GlobalData on MSN2d
Gilead and MSD to advance once-weekly HIV treatment to Phase III
The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
WKMS2d
Tennessee replaced its federal HIV funding with state money. Public health experts say the change is causing damage.
Tennessee Gov. Bill Lee made waves in early 2023, when he rejected millions of dollars in federal HIV prevention programming.
The Pharma Letter3d
Gilead and Merck tout first weekly oral HIV treatment
The companies noted that, at 48 weeks, the novel investigational combination maintained a high rate (n=49; 94.2%) of viral ...
Times West Virginian5dOpinion
Biden-Harris admin must act to ensure equitable access to HIV prevention drugs
The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...